Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

SGLT2 Receptor Inhibitor Therapeutics for Patients with Cardio Renal Metabolic Disorders: The Pharmacist’s Role

Program Overview

This CE activity is derived from content presented at the 2021 ASHP Midyear Clinical Meeting & Exhibition. The expert faculty, led by Dr. John Fanikos, will highlight the pharmacist’s role in treating patients with cardio renal metabolic disorders, utilizing SGLT2 receptor inhibitor therapeutics. The faculty will start by providing an overview of the interconnection of cardio renal metabolic ...
View Course

What Every Hospital and Critical Care Pharmacist Needs to Know About Managing Hypertensive Emergencies: Case Studies to Challenge the Experts

Program Overview

This CE activity is derived from content presented at the 2021 ASHP Midyear Clinical Meeting & Exhibition. In this education, the expert faculty, led by Dr. John Fanikos, will analyze pertinent information for hospital and critical care pharmacists related to managing hypertensive emergencies. Hypertensive emergencies lead to acute or progressive end-organ dysfunction. In these cases, blood pressure must ...
View Course
The Role of Brain Penetrant BTK Inhibitors to Improve Outcomes in Patients with Multiple Sclerosis

Program Overview

This CME/CE program is derived from content presented at the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC). The expert faculty, led by Fred D. Lublin, MD, will highlight the important emerging role of Bruton's tyrosine kinase (BTK) inhibitors as the first brain penetrant disease modifying therapy that offers opportunities to improve neuroinflammation and neurodegeneration ...
View Course
The Conundrum of Managing Chronic Coronary Disease: DPI or DAPT?

Program Overview

This CME program is derived from content presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Conference. Long-term protection from thrombotic/ischemic complications in patients with chronic coronary disease is an increasingly important topic given the aging of the population and the improved survival rates after an acute coronary syndrome (ACS). There are emerging data that support both dual antiplatelet ...
View Course
Updates in Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack

Program Overview

This CME/CNE activity will highlight updates in secondary prevention of ischemic stroke and transient ischemic attack. The expert faculty, Dr. Stephan Mayer, will first delve into the pathophysiology and disease burden of early recurrent ischemic neurovascular events. Next, Dr. Mayer will review the importance of antiplatelet therapy with both ASA and P2Y12 inhibitors in acute and early secondary ...
View Course
Update on the Long-Term Applications of Amikacin-Based Inhalation Therapeutics for the Treatment of Non-Tuberculous Mycobacterial Lung Disease

Program Overview

This CME program is derived from content presented at the Eastern Pulmonary Conference Annual Meeting. The expert faculty, Dr. Anne E. O’Donnell, will first highlight the pathophysiology, prevalence, and high-risk subgroups of non-tuberculous mycobacterial lung disease (NTM-LD). Following, Dr. O’Donnell will analyze current strategies for determining immunocompetent hosts and detecting radiographic manifestations in NTM-LD. The clinical implications of ...
View Course

Upcoming Events

The Alliance 2022 Annual Conference

January 12th – 15th, 2022

Maui Derm for Dermatologists 2022

January 24th – 28th, 2022

Advanced Curriculum for Multiple Sclerosis 2022

February 22nd, 2022

2022 American Academy of Dermatology Annual Meeting

March 25th – 29th, 2022